Scalp psoriasis can run the gamut from mild — with thin scales or plaques that are hardly discernible ... topical treatments for scalp psoriasis first, like salicylic acid.

LEO Pharma A/S, a global leader in medical dermatology, today announced the initiation of the phase 2a proof-of-concept DELTA NEXT trial. The trial aims to evaluate the efficacy and safety of ...

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

Alumis has concluded enrolment in its pivotal Phase III ONWARD programme of ESK-001 for treating plaque psoriasis.

Bimekizumab use for 4 years among patients with plaque psoriasis is associated with sustained efficacy outcomes and no new safety signals.

Although manuka honey may not treat the underlying cause of psoriasis, research suggests it may help reduce skin inflammation ...

The US FDA has cleared the first-in-class tyrosine kinase 2 (Tyk2) inhibitor as Sotyktu, and BMS says it now plans to launch the new drug later this month, aiming to mount a challenge to Amgen's ...

Tryptyr, a new dry eye treatment, is approved. Learn why Black participation in clinical trials is vital for effective, ...

The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic ...

“For patients who have the most common type of psoriasis, plaque psoriasis ... She was honored to become the first Black dermatologist to be awarded prestigious laser fellowship training ...

Patients with plaque psoriasis ... with results from the first of these (ICONIC-LEAD) due later this year. If it reaches the market, JNJ-2113 could extend J&J’s psoriasis franchise, currently ...